This study investigated how HMGB1 (high mobility group box 1 protein) affects the nasal epithelial barrier and whether autophagy mediates this effect in the context of allergic rhinitis (AR) pathogenesis.
HMGB1 impaired nasal epithelial barrier function by regulating autophagy, suggesting a mechanistic link between HMGB1-driven autophagy and epithelial barrier disruption in allergic rhinitis.
The paper abstract provides limited methodological detail — it is unclear whether findings are based on in vitro, in vivo, or clinical human data, which affects generalizability. Sample size and specific quantitative outcomes are not available from the provided source text.
HMGB1 and autophagy pathways may represent novel therapeutic targets for restoring nasal epithelial barrier integrity in allergic rhinitis. Further translational research is needed before clinical application.
